Skip to search formSkip to main contentSkip to account menu

Gleevec

Known as: Glivec 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Imatinib mesylateimatinib
STI571imatinib 400 MG Oral Tablet [Gleevec]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Is genome-guided cancer treatment hyped?
For people with advanced cancer who are running out of options, many cancer centers now offer this hope: Have your tumor9s genome… 
2011
2011
Bioavailability of a New Generic Formulation of Imatinib Mesylate 400mgTablets Versus Glivec in Healthy Male Adult Volunteers
Imatinib is a highly selective inhibitor of tyrosine kinase used in the treatment of CML and GIST. However, the cost of the drug… 
2010
2010
Response to the case report by Mattar: Generic Imatinib (Imatib, Cipla) in a patient with chronic myeloid leukemia in chronic phase
This is in response to the case report published in the January issue of this journal [1]. The published case report suggests… 
2007
2007
Utilidad de la FDG-PET en la evaluación precoz de la eficacia de imatinib (Glivec) en el tratamiento de tumores del estroma gastrointestinal
Resumen El manejo de los tumores del estroma gastrointestinal, definidos como neoplasias mesenquimales c-Kit positivas, ha… 
2007
2007
Overcoming K562Dox resistance to STI571 (Gleevec) by downregulation of P-gp expression using siRNAs
Summary Resistance to STI571 is possibly due to several mechanisms, including the overexpression of P-glycoprotein (P-gp). The… 
Review
2005
Review
2005
FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia.
The identification of the FIP1L1-PDGFRA fusion gene provides a molecular explanation for the pathogenesis of approximately half… 
2004
2004
Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts
Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR… 
2004
2004
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias
Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell… 
2003
2003
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones
Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex… 
2003
2003
[Therapeutic efficacy of imatinib mesylate (glivec) in chronic phase of myeloid leukemia].
AIM To evaluate efficacy and tolerance of glivek in chronic myeloid leukemia (CML) in patients who failed interferon-alpha (If-a…